UK markets open in 2 hours 22 minutes

Acurx Pharmaceuticals, Inc. (ACXP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.0300-0.2800 (-8.46%)
At close: 04:00PM EDT
3.0600 +0.03 (+0.99%)
After hours: 05:18PM EDT

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Sept. 30.

Sign in to post a message.
  • B
    Benuel
    Why the drop here?
  • S
    Senga
    I'm buying, looking forward to 2023. Good investment I think.👍
  • D
    Dave
    30% this week. Liking this more and more
  • V
    Vincent
    When b2?
  • b
    b
    We are now back to the pre IPO price, $4. Still a great buying opportunity.
  • t
    true red
    Great upside to $10.00. Great buy now !
  • D
    DTM
    buy now because once 2b comes through with similar results to 2a the price will blow up in anticipation of a buyout in the 30s.
    great risk to reward 👍
  • D
    Dave
    Come on!!!!!!!
  • D
    Donny
    I just bought 1.5k should i worry?
  • M
    Marc
    Incredible P2A data - patients have been 100% cured with no recurrence of CDI. P2b data should confirm and launch this thing to the moon. I got in pre-IPO and really like the odds here.
  • m
    morgan
    Summit didn’t meet their phase 3 endpoint. Summit was ACXP’s primary competition. Let the buss begin!
  • D
    Dave
    I'm in. Sounds like a winner.
  • b
    b
    I keep buying at these lows. Hard to believe it was in the 2.30;s recently, and still low volume. 2B only months away.
  • m
    morgan
    $20+ in 8 months or less
    $50+ in 18 months

    Total hidden gem
  • W
    WilliamJ
    Acurx Announces New Microbiome Data from Its Phase 2a Clinical Trial of Ibezapolstat for CDI at the 9th International C. diff. Conference

    See Yahoo headline
  • a
    adam
    Stock will be over $25 on good phase 2B data.
  • m
    morgan
    Folks. 2B is all that matters. Expect muted movement until 2B results are released. Could get a grant which would likely provide a good move but stil.. 2B. All that matters
  • D
    Dave
    Is there always a Phase 2b before going on to Phase 3? I don't recall this with other bio's that I've owned. Regardless, good news this AM.
  • D
    Dragan
    Appears good price entry IPO
  • D
    Dragan
    Here we go. Antibiotics are "easy" FDA approval. New class, targeting resistant bacteria.